Published online Jul 15, 2022. doi: 10.4239/wjd.v13.i7.521
Peer-review started: March 11, 2022
First decision: April 17, 2022
Revised: April 26, 2022
Accepted: June 22, 2022
Article in press: June 22, 2022
Published online: July 15, 2022
Processing time: 121 Days and 12.7 Hours
Due to new restrictions on the use of bisphenol A (BPA), industries are beginning to replace it with derived molecules such as bisphenol S and F (BPS and BPF). There is extensive evidence in the academic literature on the potential health effects of BPA, which is known to be a diabetogenic molecule. However, there are few publications related to new compounds derived from BPA.
To perform an epidemiological study of urinary BPS and BPF in the American National Health and Nutrition Examination Survey (NHANES) cohort, and analyze their possible relationship with diabetes mellitus.
NHANES datasets from 2013 to 2016 were used due to the urinary BPF and BPS availability. Data from 3658 adults were analyzed to perform regression analysis exploring the possible relationship between BPA-derived compounds and diabetes.
Descriptive statistics, linear regression modeling, and logistic regression analysis revealed a significant relationship between urinary BPS, but not BPF, and diabetes risk. Additionally, a relationship was observed between both compounds and hypertension and a slight relationship between BPF and dyslipidemia.
In the present study, a strong relationship between urinary BPS, not BPF, and diabetes risk has been determined. BPA substitute molecules do not exempt the population from potential health risks.
Core Tip: Molecules derived from bisphenol A (increasing use in the plastic industry and the production of heat-sensitive tickets) could be related to pathologies such as diabetes (bisphenol S) and hypertension (bisphenol S and F).